laporan dtk kelompok 3.ppt

8/16/2019 laporan dtk kelompok 3.ppt

http://slidepdf.com/reader/full/laporan-dtk-kelompok-3ppt 1/19

PLENO DTK

OLEH:KELOMPOK 3

“Farmakologi Obat Kardiovaskular”



Nama Anggota:• CHRISTOVER FISTNANDO S. (I1111202!• D"IKA HERMIA P#TRI (I1111203$!• IR"ANDA (I111120%2!• ROSALINA OKTAVIANA (I111120%!•

&IMO '#LIANSAH (I111120)2!• AN**A DOMINI#S (I111120)3!• ANATRIA AMRRA I+LIMA (I111120,-!• ANDIKA INDRA P#R"ANTORO(I111110)1!• TAN SRI ERNA"ATI (I111110,1!•

M#TA #LINDA (I1110-02%!• A*#S DARMANTO (I1110-0),!



Pm/Soang an/ta4 n5 A67an4 % ta7n4 8atang 8ngan 97an tama66a9. Ia ;ga mnga9 6/ng <9/ngat 8/ng/n4 ma4 mnta74

;antng <8<a=8<a4 <ng9a9 >a8a 98a 9a9/. Ia ;ga ma6a9anna?a6 ta6a <at 6aat <a9t/?/ta6. Pa8a maam 7a/4 na?a6 ta6a <at ;ga 9a8ang=9a8ang 8/a6a9an o7 >a6/n. 3 7a/ 5ang a /a ;gamnga9 a8an5a <at9 <8aa74 tta>/ t/8a9 ta <an5a9. &AK8/a6a9an aga9 <9ang ?9n6/n5a o7 >a6/n4 68ang9an &A&t/8a9 a8a 97an .

Da/ >m/96aan ?/6/9 8/8a>at9an :

TD 1$0@100 mmHg. HR 113 @mn/t4 T 3, C4 RR 2- @mn/t 4S>O2 B -3 .

K>aa : 9on;ngt/a anm/6 =@=4 69a /9t/9 =@=

L7 : 'VP (2 ! mH2OPmo : 6/9 (! noma4 7on9/ <a6a7 7a6 @4

7/ng @

Co : mm 6/6to/9 8/ 9at> m/ta (!4 gao> (=! HRB

8n5t na8/







T/n;aan P6ta9a

A. *aga 'antng Kong6t/? a! D?/n/6/

*aga ;antng 9ong6t/? a8aa7 9m>an g;aa 9/n/6a9/<at 9a/nan 6t9ta 8an ?ng6/ona ;antng67/ngga mnggangg 9mam>an >ng/6/an

nt/9 8an >om>a 8aa7 9 67 t<7.



T/n;aan P6ta9a

<! Et/oog/1. Pn5a9/t ;antng 9oon

2. H/>tn6/

3. Cardiomyopathy

%. Ka/nan 9at> ;antng. A/tm/a

). A9o7o 8an o<at o<atan

,. Mo9o9



Man/?6ta6/ K/n/6*aga ;antng 9// :

66a9 na?a6 8an oto>na.

*aga ;antng 9anan :

Kong6t/ na 6/6tm/9 5ang mn5<a<9an>n/ng9atan 8ma >/?4 7>atomga/4

8an 8/6tn6/ na ;ga/6.1%

T/n;aan P6ta9a





Aa6an Pm//7an O<at

a. Ca>to>/Indikasi :7/>tn6/ /ngan 6am>a/ 68ang4 7/>tn6/

<at. gaga ;antng 9ong6t/? 6ta<//ta6.

Farmakodinamik :Mng7am<at n/m >ng9on6/ang/otn6/n (ACE! G Va6o8/atato Gmn99an ta7anan a6a >/?

8an t9anan 8aa7 8an mng7am<attn6/ a/ 8an gaam 5ang noman5a8/t/m<9an o7 a8o6ton.

Ca>to>/ ;ga mnn9an preload 8anafterload .



Aa6an Pm//7an O<at

Farmakokinetik :

•A<6o>6/ : (8gn >t! ) 8/ 6aan *I.Ma9anan mnn9an a<6o>6/. D/gna9an>a8a 6aat >t 9o6ong. 30 t/9at

8ngan >ot/n >a6ma.•D/6t/<6/ : T/8a9 tm<6 Saa 8aa7ota9. Tm<6 >a6nta4 ASI 8aam ;ma79/.

•Mta<o/6m 8an E9696/: 08/mta<o/6m o7 7at/. 0 8/9696/8aam <nt9 5ang t/8a9 8/<a7 o7 g/n;a.



Aa6an Pm//7an O<at

Intraksi Obat dn !pironolakton

Ca>to>/ S>/onoaton4mngang/ 7/>to?/ ;antng </7 8a/>ngo<atan 9a>to>/ 6a;a.

Data /n/ mnn;99an <a7a>nam<a7an 6>/onoaton 8o6/6 n8a7>ngo<atan 9a>to>/ </7 ?9t/? 8aammnga7 >9m<angan 7/>to?/ ;antng

8an 8/6?ng6/ nt/9 8a/ 9a>to>/ 6a;a.



Aa6an Pm//7an O<at

<. Fo6m/8Indikasi :O<at 6tan8a nt9 gaga ;antng 8maTan8a=tan8a <n8ngan 6/9a6/ :T9anan na ;ga na/98ma >a8ma tng9a/ 8an a6/t6

E8ma >a a9t > 8/</9an ?o6m/8(I.V! 9ana 8/<t79an >nnan oma/an 96ta6a 8ngan >at4 67/nggaa/ <a/9 na 8an a7 nt/9 9anan<9ang.



Fo6m/8 G Loo> 8/t/9 9at.Png7am<at a<6o>6/ 9to/n Na@K@2C

(an6a 7n a6n8n 6gmn t<a!.Pm</an 6aa I.V n8ng a/an

8aa7 g/n;a tan>a 8/6ta/ >n/ng9atan LF*.S7/ngga4 mnga9/<at9an a<6o>6/ a/an 9to/t 8/ t</ >o96/ma 6ta ?9aa 8/6/6.Dngan <9angn5a a/an 96ta6 a9/<at8/6/64 ma9a a/an 8aa7 g/n;a mnn8an 7a /n/ a9an mn/ng9at9an a<6o>6/a/an 8an 9to/t 8/t</ >o96/ma.

Aa6an Pm//7an O<at



Aa6an Pm//7an O<at

Pa8a >n8/ta 5ang ta7 amamnggna9an ?o6m/84 > 8/</ ACEinhibitor nt9 mng7am<at 6/6tn6/?o6m/8.

ACE inhibitor ;ga 8a>at mnga7 ?96am>/ng ?o6m/8 <>a 7/>o9am/a 8an7/>omagn6m/a 9ana mnn9an

9on6nta6/ >a6ma a8o6ton.



Aa6an Pm//7an O<at

<. S>/onoa9tonIndikasi :1. (6aa a6! 7/>tn6/ 8an 8ma 5ang

?a9t.

2. Fo6m/8 8/t/9 a/n t9 mngang/9696/ 9a/m 8/6am>/ng mm><6a8/6/6.

3. Pa8a gaga ;antng 9on/9 6>/onoa9ton8/gna9an nt9 mnga7 mo8/ng.

%. M>a9an o<at >//7an t9 7/>tn6/7/>a8o6ton >/m 8an7/>a8o6ton 69n8 6>t/ a6/t6>a8a 6/o6/6 8an 6/n8om n?ot/9.



Da?ta P6ta9a

1. I9atan A>ot9 In8on6/a (IAI!. In?oma6/ S>6/a/t O<at (ISO! In8on6/a.Pn</t I6?/. 201%. Vo.%-. >>. 33142)-.2. Am/an Hat A66o/at/on. Eaat/on an8 Managmnt o? C7on/ Hat

Fa/ /n t7 A8t. 2001. Aa/a< ?om :7tt>:@@/.a7a;ona6.og@ontnt@10%@2%@2$$).?.>8? JA668 $ M/201%.

3. Hmann4 '.P.4 *oa5a4 T..4 'ao<6n4 S.'.4 "6ton4 S.A.4 R84 *.S.4*674 &.'.4 R8?/84 M.M.4 Ro87??4 R.'.4 an4 &.P.4 Rog4 V.L. In/8no? 7at ?a/ a?t m5oa8/a /n?at/on: /6 /t 7ang/ng o t/m. Am. '.E>/8m/oog5 1, (12!. 2003: 1101110,. Aa/a< ?om :7tt>:@@m.a;.o?o8;ona6.og@ontnt@1,@[email protected]/ong>m/812, $)0%).

%. Mann4 D.L. Hat Fa/ an8 Co Pmona. In: Fa/4 A.S.4 t a.41,t7 E8.Ha/6on6 P/n/>6 o? Intna M8//n. Vom 2. 1,t7 8. #SA: M*a=H/.200-. 1%%3.

. Dog7t54 R.M.4 "7/t4 H.D. E>/8m/oog5 o? Hat Fa/4 #n/6/t5 o?A9an8 N aan8. 200,. Aa/a< ?om:

7tt>:@@6>/ng.om@8a@ontnt@8omnt@8a8onoa88omnt@$,-1-%-00101 =3.>8?. JA668 $ M/ 201%.

). R/a4 K.4 2012. H5>tn6/ Hat D/6a64 "/g7t Stat #n/6/t5. Aa/a<?om: 7tt>:@@m8//n.m86a>.om@at/@1)2%%$=o/. JA668 $M/ 201%.

,. "at5. M. Pan6/ Pn5a9/t 'antng Koon >a8a Pa6/n *aga 'antngKong6t/? 8/ RS#P H. A8am Ma/9. 2012.

-. L/>4 *..H.4 */<<64 C.R.4 &64 D.*. At/oog5. In: A&C o? Hat Fa/.

#SA: M*a= H/. 2001.





1$..8g<an9.a 8/a966 >a8a tangga $ M/ 201%.

20.Anon/m4 In?oma6/ S>6/a/t O<at In8on6/a , o. %04 I9atan Sa;ana Fama6/ In8on6/a4'a9ata. 200.

21.&tam *. Katng (8!. &a6/ an8 C/n/a P7amaoog5. 11t7 84 M *a H/ 200,

22.*naan S*4 St/a<85 R4 Na?/a8/ (86! &9 Fama9oog/ 8an Ta>/. t784 'a9ata: D>atmnFama9oog/ FK#I4 200,

Da?ta P6ta9a

http://www.drugbank.ca/

http://www.drugbank.ca/

Documents

laporan dtk kelompok 3.ppt